A COMPARISON BETWEEN INTRATHECAL NALBUPHINE AND DEXMEDETOMIDINE AS ADJUVANTS TO HYPERBARIC BUPIVACAINE FOR LOWER LIMB ORTHOPEDIC SURGERIES

GEETANJALI SINGHAL; ARUN KUMAR SAXENA; GAGAN BHARADWAJ

doi:10.22159/ajpcr.2023v16i9.48157

Authors

GEETANJALI SINGHAL Department of Anaesthesiology, Jaipur National University Institute for Medical Science and Research Centre, Jaipur, Rajasthan, India.
ARUN KUMAR SAXENA Department of Anaesthesiology, Jaipur National University Institute for Medical Science and Research Centre, Jaipur, Rajasthan, India
GAGAN BHARADWAJ Department of Anaesthesiology, Jaipur National University Institute for Medical Science and Research Centre, Jaipur, Rajasthan, India

DOI:

https://doi.org/10.22159/ajpcr.2023v16i9.48157

Keywords:

Spinal anesthesia,, Sub arachnoid block, Dexmedetomidine, Nalbuphine.

Abstract

Objective: Sub arachnoid block is a reasonably safe and simple technique of regional anesthesia. This randomized double-blind study was conducted to compare the efficacy of intrathecal nalbuphine and Dexmedetomidine as adjuvant with hyperbaric bupivacaine for lower limb orthopedic surgeries.

Methods: Sixty adult patients of American Society of Anaesthesiologists physical status 1 and 2 who were scheduled for elective lower limb orthopedic surgeries were divided into two groups, D and N, of 30 each. Group D patients received dexmedetomidine 4 mcg and Group N received nalbuphine 2 mg as adjuvant along with bupivacaine heavy 0.5% (3 mL) intrathecally. Sensory and motor block characteristics and time to first rescue analgesic (intravenous tramadol 100 mg) were the primary end points and drug-related side effects such as pruritis, nausea, vomiting, and respiratory depression were taken as secondary end points. Subsequently, data were entered into Microsoft Excel spreadsheet and Statistical Package for the Social Science software version 22 was used for statistical analysis.

Results: All 60 patients showed adequate block. The onset of sensory and motor block was statistically comparable in both groups. The duration of sensory and motor block and duration of analgesia were markedly extended in dexmedetomidine group patients. There were no significant intraoperative or post-operative side-effects in both group of patients.

Conclusion: Dexmedetomidine (4 mcg) increases the sensory and motor block duration and duration of post-operative analgesia significantly more than nalbuphine (2 mg), when administered intrathecally as an adjuvant to bupivacaine (15 mg).

Downloads

Download data is not yet available.

References

Hindle A. Intrathecal opioids in the management of acute postoperative pain. Contin Educ Anaesth Crit Care Pain 2008;8:81-5.

Gunion MW, Marchionne AM, Anderson CT. Use of mixed agonist-antagonist nalbuphine in opioid based analgesia. Acute Pain 2004;6:29- 39. doi: 10.1016/j.acpain.2004.02.002

Culebras X, Gaggero G, Zatloukal J, Kern C, Marti RA. Advantages of intrathecal nalbuphine, compared with intrathecal morphine, after caesarean delivery: An evaluation of postoperative analgesia and adverse effects. Anesth Analg 2000;91:601-5. doi: 10.1097/00000539- 200009000-00019, PMID 10960384

Mukherjee A, Pal A, Agrawal J, Mehrotra A, Dawar N. Intrathecal nalbuphine as an adjuvant to sub arachnoid block: What is the most effective dose? Anesth Essays Res 2011;5:171-5. doi: 10.4103/0259- 1162.94759

Maze M, Tranquilli W. Alpha-2 adrenoreceptor agonists: Defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605. doi: 10.1097/00000542-199103000-00029

Cousins MJ, Bridenbaugh PO. Spinal neural blockade in neural blockade. In: Clinical Anesthesia and Management of Pain. 3rd ed. Philadelphia, PA: Lippincott-Raven; 1998. p. 675.

Bromage PR, Philip R. Epidural Analgesia. 1st ed. Philadelphia, PA: Saunders; 1978. p. 258, 264.

McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: A critical review. Psychol Med 1988;18:1007-19. doi: 10.1017/s0033291700009934, PMID 3078045

Sharma A, Chaudhary S, Kumar M, Kapoor R. Comparison of nalbuphine versus fentanyl as intrathecal adjuvant to bupivacaine for orthopedic surgeries: A randomized controlled double-blind trial. J Anaesthesiol Clin Pharmacol 2021;37:529-36. doi: 10.4103/joacp. JOACP_270_18, PMID 35340949

Nagaraj B, Vinay BR, Vani NV, Dayananda VP. Intrathecal nalbuphine and dexmedetomidine as adjuvants to bupivacaine versus Plain bupivacaine for Orthopedic Surgeries under subarachnoid Block: AComparative Study. Anesth Essays Res 2022;16:381-5. doi: 10.4103/ aer.aer_127_22, PMID 36620114

Michael RM, Mehta M. Comparison between dexmedetomidine and nalbuphine as an adjuvant to bupivacaine in spinal anesthesia. Int J Adv Res 2016;3:1024-45.

HalaEid EA, Shafie MA, Youssef H. Dose-related prolongation of hyperbaric bupivacaine spinal anesthesia by dexmedetomidine. Ain Shams J Anesthesiol 2011;4:83-95.

Basunia SR, Chattopadhyay S, Das A, Laha B, Bhar D, Pal R. A prospective, double-blind dose ranging study of intrathecal nalbuphine in the lower abdominal and lower limb surgeries. Indian J Pain 2016;30:198-203. doi: 10.4103/0970-5333.198060

Halder S, Das A, Mandal D, Chandra M, Ray S, Biswas MR, et al. Effect of different doses of dexmedetomidine as adjuvant in bupivacaine-induced subarachnoid block for traumatized lower limb orthopaedic surgery: A prospective, double-blinded and randomized controlled study. J Clin Diagn Res 2014;8:GC01-6. doi: 10.7860/ JCDR/2014/9670.5118, PMID 25584237

Dubey R, Bisht S. To study the effect of addition of nalbuphine to intrathecal bupivacaine used for elderly patient in lower abdominal surgeries under spinal anesthesia: A Randomized double blinded control study. J Evol Med Dent Sci 2014;3:14364-71.